Funded Tech Companies

RenaMed Biologics

RenaMed Biologics, based in Lincoln, received equity investments from Merlin BioMed Group, Edbi and MDS Capital.

Company Overview

Contact Information

Company Background Information

Overview

RenaMed Biologics, Inc. is the leading clinical stage company focused on the development of proprietary Bio-Replacement Therapies for critical disease states involving compromised kidney function.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/7/2006

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gregory Phelps

        

Chief Financial Officer

Mark Fitzpatrick

        

Chief Medical Officer

Bradley Maroni

        

Chief Scientific Officer

David Humes

        

Company Investors

• Merlin BioMed Group
• Edbi
• MDS Capital (Gerry Brunk)
• TVM Capital (Gert Caspritz)
• DFJ Portage Venture Partners
• Seaflower Ventures

Browse more funded tech companies:

Renalys Pharma | Renatus Robotics

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary